Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Effect of diabetes on in vivo metabolism of (/sup 35/S)-labeled glomerular basement membrane

Journal Article · · Diabetes; (United States)
OSTI ID:7013775
Glomerular basement membrane (GBM) was labeled in vivo by the injection of tracer amounts of (/sup 35/S)-sulfate into normal and streptozotocin-diabetic rats. The biosynthesis and turnover of sulfated glycosaminoglycans in the GBM was determined from the specific activity of (/sup 35/S) after pronase digestion of basement membranes purified from glomeruli isolated 1-7 days after injection. Peak radiolabeling of both normal and diabetic GBM occurred 24 h after injection and, when corrected for differences in serum sulfate specific activities, was less in diabetic than in normal samples. The specific activity of GBM sulfate, expressed as cpm/microgram uronic acid, progressively diminished over the ensuing period of study in both normal and diabetic samples. The rate of decrease in specific activity of (/sup 35/S)-labeled GBM was not significantly different in diabetic preparations compared with that in normal controls. The findings are compatible with diminished sulfation and/or production but normal turnover of glycosaminoglycans in the renal GBM in experimental diabetes.
Research Organization:
Univ. of Medicine and Dentistry, Newark, NJ
OSTI ID:
7013775
Journal Information:
Diabetes; (United States), Journal Name: Diabetes; (United States) Vol. 33:1; ISSN DIAEA
Country of Publication:
United States
Language:
English